ID

31875

Description

A Study of Combination Treatment With MabThera (Rituximab) and RoActemra (Tocilizumab) Versus RoActemra in Patients With Rheumatoid Arthritis With an Incomplete Response to Methotrexate; ODM derived from: https://clinicaltrials.gov/show/NCT00845832

Link

https://clinicaltrials.gov/show/NCT00845832

Keywords

Versions (1)
  1. 10/5/18 10/5/18 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

October 5, 2018

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Rheumatoid Arthritis NCT00845832

English

Eligibility Rheumatoid Arthritis NCT00845832

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
adult patients, 18-65 years of age;
Description

Adult | Age

Data type

boolean

Alias
UMLS CUI [1]
C0001675
UMLS CUI [2]
C0001779
rheumatoid arthritis, functional status i-iii;
Description

Rheumatoid Arthritis Functional Status Class

Data type

boolean

Alias
UMLS CUI [1,1]
C0003873
UMLS CUI [1,2]
C0598463
UMLS CUI [1,3]
C0456387
sjc>=4 (28 joint count) and tjc>=4 (28 joint count) at screening and baseline;
Description

Swollen 28 joint count | Tender 28 joint count

Data type

boolean

Alias
UMLS CUI [1]
C2711873
UMLS CUI [2]
C2711398
rf and/or anti-ccp positive;
Description

Rheumatoid factor positive | Anti-cyclic citrullinated peptide antibody positive

Data type

boolean

Alias
UMLS CUI [1]
C0151379
UMLS CUI [2]
C2609056
may have failed up to 1 approved anti-tnf agent (infliximab, etanercept or adalimumab);
Description

Anti-tumor necrosis factor alpha drug Quantity failed | infliximab | Etanercept | adalimumab

Data type

boolean

Alias
UMLS CUI [1,1]
C1562242
UMLS CUI [1,2]
C1265611
UMLS CUI [1,3]
C0231175
UMLS CUI [2]
C0666743
UMLS CUI [3]
C0717758
UMLS CUI [4]
C1122087
inadequate response to methotrexate, at a dose of 7.5-25mg weekly for at least 12 weeks, at a stable dose for past 4 weeks.
Description

Methotrexate Dose Stable U/week | Response Inadequate

Data type

boolean

Alias
UMLS CUI [1,1]
C0025677
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C0205360
UMLS CUI [1,4]
C0560588
UMLS CUI [2,1]
C1704632
UMLS CUI [2,2]
C0205412
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
rheumatic autoimmune disease other than rheumatoid arthritis, or significant systemic involvement secondary to rheumatoid arthritis;
Description

Autoimmune Disease Rheumatic | Exception Rheumatoid Arthritis | Rheumatoid arthritis with systemic involvement

Data type

boolean

Alias
UMLS CUI [1,1]
C0004364
UMLS CUI [1,2]
C0035435
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0003873
UMLS CUI [3]
C0494896
history of, or current, inflammatory joint disease other than rheumatoid arthritis;
Description

Inflammatory joint disease | Exception Rheumatoid Arthritis

Data type

boolean

Alias
UMLS CUI [1]
C0683381
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0003873
diagnosis of juvenile idiopathic arthritis and/or rheumatoid arthritis before age 16;
Description

Juvenile arthritis | Juvenile rheumatoid arthritis | Age

Data type

boolean

Alias
UMLS CUI [1]
C3495559
UMLS CUI [2]
C3714757
UMLS CUI [3]
C0001779
significant cardiac or pulmonary disease;
Description

Heart Disease | Lung disease

Data type

boolean

Alias
UMLS CUI [1]
C0018799
UMLS CUI [2]
C0024115
previous treatment with any biologic agent for rheumatoid arthritis (other than infliximab, etanercept or adalimumab).
Description

Biological agent Rheumatoid Arthritis | Exception Infliximab | Exception Etanercept | Exception Adalimumab

Data type

boolean

Alias
UMLS CUI [1,1]
C0005515
UMLS CUI [1,2]
C0003873
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0666743
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0717758
UMLS CUI [4,1]
C1705847
UMLS CUI [4,2]
C1122087
Back to the top of the page

Similar models

Eligibility Rheumatoid Arthritis NCT00845832

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Adult | Age
Item
adult patients, 18-65 years of age;
boolean
C0001675 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
Rheumatoid Arthritis Functional Status Class
Item
rheumatoid arthritis, functional status i-iii;
boolean
C0003873 (UMLS CUI [1,1])
C0598463 (UMLS CUI [1,2])
C0456387 (UMLS CUI [1,3])
Swollen 28 joint count | Tender 28 joint count
Item
sjc>=4 (28 joint count) and tjc>=4 (28 joint count) at screening and baseline;
boolean
C2711873 (UMLS CUI [1])
C2711398 (UMLS CUI [2])
Rheumatoid factor positive | Anti-cyclic citrullinated peptide antibody positive
Item
rf and/or anti-ccp positive;
boolean
C0151379 (UMLS CUI [1])
C2609056 (UMLS CUI [2])
Anti-tumor necrosis factor alpha drug Quantity failed | infliximab | Etanercept | adalimumab
Item
may have failed up to 1 approved anti-tnf agent (infliximab, etanercept or adalimumab);
boolean
C1562242 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0231175 (UMLS CUI [1,3])
C0666743 (UMLS CUI [2])
C0717758 (UMLS CUI [3])
C1122087 (UMLS CUI [4])
Methotrexate Dose Stable U/week | Response Inadequate
Item
inadequate response to methotrexate, at a dose of 7.5-25mg weekly for at least 12 weeks, at a stable dose for past 4 weeks.
boolean
C0025677 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
C0560588 (UMLS CUI [1,4])
C1704632 (UMLS CUI [2,1])
C0205412 (UMLS CUI [2,2])
Item Group
C0680251 (UMLS CUI)
Autoimmune Disease Rheumatic | Exception Rheumatoid Arthritis | Rheumatoid arthritis with systemic involvement
Item
rheumatic autoimmune disease other than rheumatoid arthritis, or significant systemic involvement secondary to rheumatoid arthritis;
boolean
C0004364 (UMLS CUI [1,1])
C0035435 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C0003873 (UMLS CUI [2,2])
C0494896 (UMLS CUI [3])
Inflammatory joint disease | Exception Rheumatoid Arthritis
Item
history of, or current, inflammatory joint disease other than rheumatoid arthritis;
boolean
C0683381 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0003873 (UMLS CUI [2,2])
Juvenile arthritis | Juvenile rheumatoid arthritis | Age
Item
diagnosis of juvenile idiopathic arthritis and/or rheumatoid arthritis before age 16;
boolean
C3495559 (UMLS CUI [1])
C3714757 (UMLS CUI [2])
C0001779 (UMLS CUI [3])
Heart Disease | Lung disease
Item
significant cardiac or pulmonary disease;
boolean
C0018799 (UMLS CUI [1])
C0024115 (UMLS CUI [2])
Biological agent Rheumatoid Arthritis | Exception Infliximab | Exception Etanercept | Exception Adalimumab
Item
previous treatment with any biologic agent for rheumatoid arthritis (other than infliximab, etanercept or adalimumab).
boolean
C0005515 (UMLS CUI [1,1])
C0003873 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C0666743 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0717758 (UMLS CUI [3,2])
C1705847 (UMLS CUI [4,1])
C1122087 (UMLS CUI [4,2])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial